NEW YORK--(BUSINESS WIRE)--Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the ...

HCPs and key opinion leaders (KOLs) have always been central to the success of new therapies, shaping how innovations reach patients and influencing the trajectory of scientific understanding within ...

The study will aim to prove oil-based seaweed product has the potential to be more effective than existing solutions Dr. Mallory Honan, Symbrosia's product and animal science lead, spoke about the ...

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 9:20 AM ESTCompany ParticipantsDavid Happel ...

Caris Life Sciences® today announced the presentation of a study that found drugs targeting specific pathways may have potentially significant benefit in a select subset of patients with uterine ...

Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost. Delayed clinical trials, regulatory approvals, and ...

Atai Life Sciences announced positive results from Beckley Psytech's Phase 2a study of BPL-003, an adjunctive treatment for patients with treatment-resistant depression (TRD) who are already on ...

LONDON--(BUSINESS WIRE)--Builds Bio+, the leading life science membership organization connecting key stakeholders across regional clusters, announces the launch of its London/UK chapter. This ...

Develop your career in the life sciences sector with one of our online programmes taught by experts from Queen Mary’s Faculty of Medicine and Dentistry. Our experts in biomedical sciences can help you ...

KAILUA-KONA, Hawaii , Jan. 18, 2024 /PRNewswire/ -- Symbrosia, a Hawaii-based cleantech startup that uses seaweed to drastically reduce livestock methane emissions, is excited to announce a study with ...